Richter, J. R., Beksac, M., Corso, A., Papadimitropoulou, K., Cooper, L., Meader, N., Purser, M., Bates, A., Sapra, S., Ballew, N. (2026). Matching-adjusted indirect comparison (MAIC) for belantamab mafodotin (belamaf) with pomalidomide and dexamethasone (BPd) vs daratumumab with pomalidomide and dexamethasone (DPd) in relapsed/refractory multiple myeloma (RRMM).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e19574